Condition: DLBCL - Diffuse Large B Cell Lymphoma · Lymphoma · Sponsor: Ruijin Hospital
To collect and evaluate the data of real-world treatment regimen, efficacy, safety and survival information of DLBCL patients with different genetic suptypes
This description comes directly from the study's public registry record.
Weili Zhao · +862164370045 · zwl_trial@163.com
Pengpeng Xu · +862164370045 · pengpeng_xu@126.com
Always discuss trial participation with your own doctor first.
| Ruijin Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06026488